Literature DB >> 24421828

Potential consequences of essential drug shortages in Canada: Brain abscess due to Nocardia farcinica associated with dapsone prophylaxis for Pneumocystis jirovecii pneumonia.

Terry C Wuerz1, Eric J Bow2, Matthew D Seftel3.   

Abstract

In 2012, Canadian pharmacies experienced a shortage of trimethoprim-sulfamethoxazole tablets. Drug shortages may result in unintended clinical consequences such as infection with pathogens against which the alternative medication is ineffective. This is highlighted in the present article, which describes a case of brain abscess due to Nocardia species that developed while receiving dapsone as an alternative for prophylaxis against Pneumocystis jirovecii pneumonia in a highly immune-suppressed patient. Clinicians should be cognizant of these issues when prescribing alternative agents.

Entities:  

Keywords:  Drug shortage; Nocardia; PCP prophylaxis; Pneumocystis jirovecii; Trimethoprim-sulfamethoxazole

Year:  2013        PMID: 24421828      PMCID: PMC3852454          DOI: 10.1155/2013/805797

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  9 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.

Authors:  Anton Y Peleg; Shahid Husain; Zubair A Qureshi; Fernanda P Silveira; Molade Sarumi; Kathleen A Shutt; Eun J Kwak; David L Paterson
Journal:  Clin Infect Dis       Date:  2007-04-03       Impact factor: 9.079

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

Authors:  Bertram L Kasiske; Martin G Zeier; Jeremy R Chapman; Jonathan C Craig; Henrik Ekberg; Catherine A Garvey; Michael D Green; Vivekanand Jha; Michelle A Josephson; Bryce A Kiberd; Henri A Kreis; Ruth A McDonald; John M Newmann; Gregorio T Obrador; Flavio G Vincenti; Michael Cheung; Amy Earley; Gowri Raman; Samuel Abariga; Martin Wagner; Ethan M Balk
Journal:  Kidney Int       Date:  2009-10-21       Impact factor: 10.612

5.  Canada falls short on safeguarding its drug supply.

Authors:  Matthew B Stanbrook; Rosemary M Killeen
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

6.  A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.

Authors:  B C Fox; H W Sollinger; F O Belzer; D G Maki
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

7.  Nocardiosis in Quebec, Canada, 1988-2008.

Authors:  J Tremblay; L Thibert; I Alarie; L Valiquette; J Pépin
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

8.  Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.

Authors:  A Carr; B Tindall; B J Brew; D J Marriott; J L Harkness; R Penny; D A Cooper
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

Review 9.  Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.

Authors:  Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Mayo Clin Proc       Date:  2007-09       Impact factor: 7.616

  9 in total
  1 in total

1. 

Authors:  Marine Floutier; Suzanne Atkinson; Denis Lebel; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2021-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.